Slide

Monthly seminar series on the topic of Medicine & Society. Register here!

Slide

Junior Membership:
Be actively involved and take a leadership role in CancerPrev initiatives

TAD07201

This was World Cancer Day 2023!
Read the report and watch the recording here

Afbeelding van WhatsApp op 2023-12-20 om 15.51.12_4dd3ae3d

Find out more about

TAD06885

La Journée mondiale contre le cancer 2025 approche à grands pas !

Second International Conference on Sexual Dimorphism in Cancer
Second International Conference on Sexual Dimorphism in Cancer

The field of Sexual Dimorphism in Cancer has seen significant advancements, with disparities in cancer incidence, survival rates, and treatment effectiveness being actively researched. The conference focuses on the impact of sex hormones and chromosomes on cancer susceptibility, with an emphasis on (epi)genetics, sex hormones, cancer cell biology, metabolism and the immune system.

IMG_2548

Find out more about

TAD06881
Be part of a local network of like-minded people and connect to a broad community with the same goals.

Get access to education and training, for both experts and students.

Amplify your voice locally to increase awareness on cancer prevention worldwide
Become a member
World Cancer Day 2024

The Cancer Prevention Forum took place on Sunday, February 4th, 2024, and raised awareness about different types of cancer (skin, breast and lung cancer) and ways to prevent them.

IMG_2742

Coming Soon! The Cancerprev Educational Fellowship Program.

Breast cancer Research
person with pink band on her left hand

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Brisken Lab:
Laboratory of Breast Cancer Research and Prevention

Slide

Dotto lab:
Sex Hormones and Epigenetics in Skin Aging

previous arrow
next arrow

Education, training and positions

Dr. Dotto was educated at the University of Turin, Italy, where he received his MD in 1979. He then earned his PhD in bacteriophage genetics at the Rockefeller University, New York, in 1983. He moved for his postdoctoral training at the Whitehead Institute/MIT in Cambridge Mass. and subsequently joined Yale University, New Haven, Connecticut, as assistant professor of Pathology in 1987. He was promoted to the rank of associate professor in 1992 and soon after moved to Harvard Medical School, in the newly established Cutaneous Biology Research Center. In 2000 he obtained the full professorship at Harvard Medical School and a Biologist position at Massachusetts General Hospital.  In 2002 he accepted a position of Professor in the Department of Biochemistry at the University of Lausanne (UNIL), while retaining his position of Biologist at Massachusetts General Hospital. He has directed the UNIL PhD program in Cancer and Immunology from 2007 to 2019 and has been responsible for Biochemistry teaching to Medical Students since 2004. Since Aug. 1st 2021 he is emeritus professor of the Department of Biochemistry and Immmunobiology at UNIL. He is co-founder and director of the International Cancer Prevention Institute, established in Epalinges/Lausanne in 2016.